Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00893763 · ClinicalTrials.gov registry record · Phase 2
Strategies To Prevent Pneumonia 2 (SToPP2)
A Phase 2 study, sponsored by University of South Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 314
- Enrollment target
NCT00893763 is a Phase 2 study that has completed, run by University of South Florida. The registered enrollment target is 314 participants.
The verdict
NCT00893763, a Phase 2 study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 314 participants
- Enrollment target
Study Summary
Ventilator-associated pneumonia (VAP) is a serious complication in mechanically ventilated critically ill patients. The intervention tested in this project (swabbing the mouth with chlorhexidine before the endotracheal tube is inserted) could reduce the risk of ventilator-associated pneumonia.
Interventions
- PROCEDURE Control
- PROCEDURE Pre-intubation CHX
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 314 participants |
| Start Date | 2008-09 |
| Est. Completion | 2012-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00893763
The ClinicalTrials.gov registry entry for NCT00893763 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 314 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT00893763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00893763 about?
NCT00893763 is a clinical study titled "Strategies To Prevent Pneumonia 2 (SToPP2)". Ventilator-associated pneumonia (VAP) is a serious complication in mechanically ventilated critically ill patients. The intervention tested in this project (swabbing the mouth with chlorhexidine before the endotracheal tube is inserted) could reduce the risk of ventilator-associated pneumonia.
What is the current status of trial NCT00893763?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 314 participants. The study started on 2008-09. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00893763?
The interventions under investigation include: Control (PROCEDURE), Pre-intubation CHX (PROCEDURE).
Who is sponsoring clinical trial NCT00893763?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.